Martin Ingelsson
Martin Ingelsson publishes mostly in Physiology, Molecular Biology and Neurology, on topics such as Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments and Genetic Associations and Epidemiology.
- World rank
- #36,038 of 7,710,434 ranked researchers
- Rank in Sweden
- #229 of 71,437
- Works
- 345
- Citations
- 40k
- Citations per work
- 116.9
What does Martin Ingelsson research?
Martin Ingelsson's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (25%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13338.5%
- Medicine13338.5%
- Life Sciences11232.6%
- Everything else10028.9%
- 1Physiology19% of their works
- 2Molecular Biology16% of their works
- 3Neurology15% of their works
- 4Genetics9% of their works
- 5Cellular and Molecular Neuroscience7% of their works
- 6Psychiatry and Mental health5% of their works
Research topics
- Alzheimer's disease research and treatments
- Parkinson's Disease Mechanisms and Treatments
- Genetic Associations and Epidemiology
- Dementia and Cognitive Impairment Research
- Neurological disorders and treatments
- Bioinformatics and Genomic Networks
- Neuroinflammation and Neurodegeneration Mechanisms
- Nuclear Receptors and Signaling
Which keywords describe Martin Ingelsson's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Parkinson's Disease, Dopaminergic Neurons and a-Synuclein.
- NR4A2
- Microglia
- Astrocytes
- Deep Brain Stimulation
- Genome-Wide Association
- Alzheimer's Disease
- Genetic Risk Factors
- Parkinson's Disease
- Amyloid Hypothesis
- Oxidative Stress
- Neurodegeneration
- Neuroinflammation
- Tau Pathology
- Dopaminergic Neurons
- a-Synuclein
- Genetic Variation
- Mild Cognitive Impairment
- Subthalamic Nucleus
- Gene Set Enrichment Analysis
- Protein-Protein Interaction Networks
- Nurr1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Neurodegeneration2874 topics
- Oxidative Stress2422 topics
- Neuroinflammation1912 topics
- Amyloid Hypothesis1681 topic
- Tau Pathology1681 topic
- Parkinson's Disease1203 topics
- Dopaminergic Neurons962 topics
- Genetic Risk Factors741 topic
- a-Synuclein741 topic
- Alzheimer's Disease431 topic
- Genetic Variation431 topic
- Genome-Wide Association431 topic
- Mild Cognitive Impairment431 topic
- Deep Brain Stimulation241 topic
- Subthalamic Nucleus241 topic
- Astrocytes231 topic
- Gene Set Enrichment Analysis231 topic
- Microglia231 topic
- Protein-Protein Interaction Networks231 topic
- NR4A2221 topic
- Nurr1221 topic
Where does Martin Ingelsson work?
Martin Ingelsson's main affiliation in the publication record is Uppsala University, Sweden.
How many publications and citations does Martin Ingelsson have?
OpenAlex counts 345 works and 40,325 citations for Martin Ingelsson, an h-index of 78, ranking #36,038 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Martin Ingelsson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.